BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23172081)

  • 1. Nrf2 expression is associated with poor outcome in osteosarcoma.
    Park JY; Kim YW; Park YK
    Pathology; 2012 Dec; 44(7):617-21. PubMed ID: 23172081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of heat shock proteins in osteosarcomas.
    Moon A; Bacchini P; Bertoni F; Olvi LG; Santini-Araujo E; Kim YW; Park YK
    Pathology; 2010; 42(5):421-5. PubMed ID: 20632817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic relevance of centromere protein A in primary osteosarcoma.
    Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH
    Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of RANK signalling on survival and chemotherapy response in osteosarcoma.
    Bago-Horvath Z; Schmid K; Rössler F; Nagy-Bojarszky K; Funovics P; Sulzbacher I
    Pathology; 2014 Aug; 46(5):411-5. PubMed ID: 24842377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the Nrf2 and Keap1 proteins and their clinical significance in osteosarcoma.
    Zhang J; Wang X; Wu W; Dang H; Wang B
    Biochem Biophys Res Commun; 2016 Apr; 473(1):42-46. PubMed ID: 26987716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant chemotherapy.
    Borys D; Canter RJ; Hoch B; Martinez SR; Tamurian RM; Murphy B; Bishop JW; Horvai A
    Hum Pathol; 2012 Nov; 43(11):1948-54. PubMed ID: 22578565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
    Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
    Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasculogenic mimicry: a new prognostic sign of human osteosarcoma.
    Ren K; Yao N; Wang G; Tian L; Ma J; Shi X; Zhang L; Zhang J; Zhou X; Zhou G; Wu S; Sun X
    Hum Pathol; 2014 Oct; 45(10):2120-9. PubMed ID: 25123071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary investigation of Beta-hCG expression in patients with osteosarcoma.
    Masrouha KZ; Khattab R; Tawil A; Abdallah A; Saghieh S; Haidar R; Abboud M; Khoury NJ
    J Bone Joint Surg Br; 2012 Mar; 94(3):419-24. PubMed ID: 22371553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
    Zhu Y; Zhou J; Ji Y; Yu B
    Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
    Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
    BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of increases in tumor volume after neoadjuvant chemotherapy on the outcome of stage II osteosarcoma regardless of histological response.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jung ST; Jeon DG
    J Orthop Sci; 2009 May; 14(3):292-7. PubMed ID: 19499296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of hypoxia-inducible factor 1α in osteosarcoma and its value in predicting chemosensitivity].
    Chen Y; Wang CM; Shi YQ; Yang Y
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):899-904. PubMed ID: 23336375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
    Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
    Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.
    Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M
    Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-α/β receptor as a prognostic marker in osteosarcoma.
    Kubo T; Shimose S; Matsuo T; Fujimori J; Arihiro K; Ochi M
    J Bone Joint Surg Am; 2011 Mar; 93(6):519-26. PubMed ID: 21411701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANKL expression is related to treatment outcome of patients with localized, high-grade osteosarcoma.
    Lee JA; Jung JS; Kim DH; Lim JS; Kim MS; Kong CB; Song WS; Cho WH; Jeon DG; Lee SY; Koh JS
    Pediatr Blood Cancer; 2011 May; 56(5):738-43. PubMed ID: 21370405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between fluid-fluid levels on initial MRI and the response to chemotherapy in stage IIb osteosarcoma.
    Jeon DG; Cho WH; Song WS; Kong CB; Cho SH; Lee JW; Lee SY
    Ann Surg Oncol; 2014 Jun; 21(6):1956-62. PubMed ID: 24577812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XB130 expression in human osteosarcoma: a clinical and experimental study.
    Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
    Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome.
    Yang QC; Zeng BF; Dong Y; Shi ZM; Jiang ZM; Huang J
    Jpn J Clin Oncol; 2007 Feb; 37(2):127-34. PubMed ID: 17237146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.